ГОСТ ISO 10993-7— 2011
(33J НАСКЕТТ. R. BROWN. R„ BUSCHBOOM. R.. CLARK. M.. MILLER. R.. MUSIC. R.. ROWE. S.. SCHIRMER. R. and
SIKOV, M. Teratogenic Study of Ethylene Oxide and Propylene Oxide and n-8utyl Acetate (NIOSH Contract No.
21 0-00-001 3). Richland. WA: Battelle Pacific Northwest Laboratories. 1982. (Cited in EPA. 1985.)
[34]HANDLOS. V. Determination of gas residuals in ethylene oxide sterilized materials — A literature survey. Archiv.
Pharm. Chemi. Sci. 4 1976; pp. 73—80
[35]HANDLOS. V. The hazards of ethylene oxide sterilization. Arch. Pharm. Chemi. Sci. 7 1979; pp. 939—949
[36] HARTMAN. P.A. and BOWMAN. P.B. Simple GLC determination of ethylene oxide and its reaction products in drug
and formulations. J. Pharm. Sci. 66(6) 1977; pp. 789—792
[37] Health Industry Manufacturers’ Association. Guidelines for the Analysis of Ethylene Oxide Residues in Medical
Devices (HIMA Document No. 1. Vol. 2). Washington. DC: HIMA. 1980
[38] HOLLINGSWORTH. R.. ROWE. V.. OYEN. F., MCCALLISTER. D. and SPENCER. H. Toxicity of ethylene oxide
determined on experimental animals. AMA Arch. Ind. Health. 13 1956; pp. 217—227
[39] HUBAUX, A. and GILBERT. V. Decision and detection limits for linear calibration curves. Anal. Chem. 42(8) 1970;
pp. 849—855
[40]Improved detection and separation of glycols and ethylene oxide residues using GC. (Bulletin 789). Supelco, Inc.;
1980
[41] JACOBSON. K.. HACKLEY. E. and FEINSILVER, L. The toxicity of inhaled ethylene oxide and propylene oxide
vapors. AMA Arch. Ind. Health. 13 1956; pp. 237—244
[42]Japan Association of Disposable Medical Device Industries. Guideline for ethylene oxide sterilization of disposable
medical devices (second edition). Dec. 1989
[43]JOHNSON. M. Metabolism of chloroethanol in the rat. Biochem. Pharmacol. 16 1967a: pp. 185— 199
[44]JOHNSON.
M.
Detoxication of ethylene chlofohydnn. Fd. Cosmet. Tox. 5 1967b; p. 499
[45] JONES-PRICE. C.. KIMMEL. T.. MARKES. T.. LEDOUX. T. REEL. J.. FISCHER. P.. LANGHOFF-PASCHKE. L. and
MARR, M. Teratologic Evaluation of Ethylene Oxide (CAS No. 75-78-8) in New Zealand White Rabbits (Final report
RB80-EO, NIEHS Contract No. I-ES-2127). Research Triangle Park, NC: National Institute of Environmental
Health Sciences. 1982. (Cited in EPA. 1985)
[46] JONES-PRICE. C.. MARKS.!. LEDOUX.!, REEL. J., FISCHER. R. LANGHOFF-PASCHKE. L.. MARR. M. and
KIMMEL. C. Teratologic Evaluation of Ethylene Chlorohydrin (CAS No. 107-07-3) in New Zealand White Rabbits
(PB85-170959). Research Triangle Park. NC: National Institute of Environmental Health Sciences. 1985a
[47] JONES-PRICE. C„ MARKS. T. LEDOUX. T. REEL. J.. FISCHER, R. LANGHOFF-PASCHKE. L.. MARR. M. and
KIMMEL. C. Teratologic Evaluation of Ethylene Chlorohydrin (CAS No. 107-07-3) in CD-1 mice (PB85-172104).
Research Triangle Park. NC: National Institute of Environmental Health Sciences. 1985b
[48] KAREL. L., LANDING. B. and HARVEY, T. The intrapentoneal toxicity of some glycols, glycol ethers, glycol esters
and phthalates in mice. Fed. Proceedings. 6 1947; p. 342
[49] KASHTOCK. M. Use of specific retention volumes in evaluation of various types of columns for use in the trace
determination of ethylene glycol by gas chromatography. J. Chromatogr. 176 1979: pp. 25—35
[50] KAYE. M.M. and NEVELL. T.G. Statistical evaluation of methods using headspace gas chromatography for the
determination of ethylene oxide. Analyst. 110 1985; pp. 1067—1071
[51] KIKUCHI. H.. NAKAMURA. A. and TSUJI, K. Gas chromatographic determination with electron capture detection of
residual ethylene oxide in intraocular lenses. J. Assoc. Off. Anal. Chem. 71 1988: pp. 1057— 1062
[52] KROES. R.. BOCK. B. and MARTIS. L. Ethylene oxide extraction and stability in water and blood. Personal communi
cation to the AAMI Committee. Jan 1985
[53] KULKARNI. R.K., BARTAK. D.. OUSTERHOUT. D.K. and LEONARD. F. Determination of residual ethylene oxide in
catheters by gas-liquid chromatography. J. Biomed. Mat. Res. 2 1968; pp. 165— 171
[54] LABORDE. J. and KIMMEL. C. The teratogenicity of ethylene oxide administered intravenously to mice. Tox. Appl.
Pharm. 56 1980; pp. 16—22
[55] LANDEN. W.O.. THOMPSON. D.W. and FLOYD. K.M. Determination of ethylene oxide and ethylene glycol in wet
surgical dressings. FDA By-Lines. No. 2. 1971
[56] LATVEN, A. and MOLITOR. H. Comparison of the toxic, hypnotic and irritating properties of eight organic solvents.
J. Pharm. Exp. Ther. 65 1939; pp. 89—94
[57] LAWRENCE. W.. TURNER. J.and AUTIAN. J. Toxicity ofethylenechlorohydrin I:Acute toxicity studies. J. Pharm. Sci.
60(4) 1971a; pp. 568—571
[58] LAWRENCE. W.. ITOH. K.. TURNER. J. and AUTIAN. J. Toxicity of ethylene chlorohydrin II: Subchronic toxicity and
special tests. J. Pharm. Sd. 60(8) 1971 b: pp. 1163— 1168
[59] LAWRENCE. W.. DILLINGHAM. E„ TURNER. J. and AUTIAN. J. Toxicity profile of chloroacetaldehyde. J. Pharm.
Sci. 61(1) 1972; pp. 19—25
[60] LEE. H.T., DANIEL. A. and WALKER. C. Conformance test procedures (CTP) for verifying the labeling claims for
precision, bias, and interferences in m-vilro diagnostic devices used for the quantitative measurement of analytes
in human body fluids. In: Bureau of Medical Devices Biometrics Report 8202. Silver Spring. MD: Food and Drug
Administration. Apr. 1982
35